Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Integrin Ī±11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence.

Ando T, Kage H, Matsumoto Y, Zokumasu K, Yotsumoto T, Maemura K, Amano Y, Watanabe K, Nakajima J, Nagase T, Takai D.

Cancer Sci. 2020 Jan;111(1):200-208. doi: 10.1111/cas.14257. Epub 2019 Dec 18.

2.

Preoperative intervention with long-acting bronchodilators for the reduction of postoperative pulmonary complications in untreated patients with obstructive lung disease.

Mikami Y, Jo T, Matsuzaki H, Ishimori T, Saito M, Sakamoto Y, Yamauchi Y, Takai D, Yatomi Y, Nagase T.

Clin Respir J. 2019 Nov 12. doi: 10.1111/crj.13105. [Epub ahead of print]

PMID:
31715066
3.

Minimum environmental enrichment is effective in activating antitumor immunity to transplanted tumor cells in mice.

Takai D, Abe A, Miura H, Tanaka S, Komura JI.

Exp Anim. 2019 Nov 6;68(4):569-576. doi: 10.1538/expanim.19-0055. Epub 2019 Jul 11.

4.

Small lung tumor biopsy samples are feasible for high quality targeted next generation sequencing.

Kage H, Kohsaka S, Shinozaki-Ushiku A, Hiraishi Y, Sato J, Nagayama K, Ushiku T, Takai D, Nakajima J, Miyagawa K, Aburatani H, Mano H, Nagase T.

Cancer Sci. 2019 Aug;110(8):2652-2657. doi: 10.1111/cas.14112. Epub 2019 Jun 21.

5.

CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.

Ito T, Nakamura A, Tanaka I, Tsuboi Y, Morikawa T, Nakajima J, Takai D, Fukayama M, Sekido Y, Niki T, Matsubara D, Murakami Y.

Cancer Sci. 2019 Jul;110(7):2284-2295. doi: 10.1111/cas.14040. Epub 2019 May 29.

6.

Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens.

Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F, Takahashi K, Takamochi K, Suzuki K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, Nagase T, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku M, Miyazono K, Miyagawa K, Aburatani H, Mano H.

Cancer Sci. 2019 Apr;110(4):1464-1479. doi: 10.1111/cas.13968. Epub 2019 Mar 5.

7.

Spontaneous Transdifferentiation from Small Cell Lung Carcinoma to Squamous Cell Carcinoma.

Watanabe K, Kage H, Shinozaki-Ushiku A, Kohsaka S, Takai D, Nakajima J, Miyagawa K, Aburatani H, Mano H, Nagase T.

J Thorac Oncol. 2019 Feb;14(2):e31-e34. doi: 10.1016/j.jtho.2018.10.159. No abstract available.

PMID:
30683296
8.

Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.

Abe M, Watanabe K, Shinozaki-Ushiku A, Ushiku T, Abe T, Fujihara Y, Amano Y, Zong L, Wang CP, Kubo E, Inaki R, Kinoshita N, Yamashita S, Takai D, Ushijima T, Nagase T, Hoshi K.

BMC Cancer. 2019 Jan 11;19(1):52. doi: 10.1186/s12885-019-5277-1. Review.

9.

Chronic exposure to gamma irradiation at low-dose rates accelerates blood pressure decline associated with aging in female B6C3F1 mice.

Takai D, Abe A, Komura JI.

Int J Radiat Biol. 2019 Mar;95(3):347-353. doi: 10.1080/09553002.2019.1552808. Epub 2019 Jan 3.

PMID:
30513245
10.

Three Severe Cases of Viral Infections with Post-Kidney Transplantation Successfully Confirmed by Polymerase Chain Reaction and Flow Cytometry.

Nakanishi K, Kaito H, Ogi M, Takai D, Fujimura J, Horinouchi T, Yamamura T, Minamikawa S, Ninchoji T, Nozu K, Imadome KI, Iijima K.

Case Rep Nephrol Dial. 2018 Sep 25;8(3):198-206. doi: 10.1159/000493092. eCollection 2018 Sep-Dec.

11.

Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor.

Watanabe K, Yasumoto A, Amano Y, Kage H, Goto Y, Yatomi Y, Takai D, Nagase T.

PLoS One. 2018 Sep 7;13(9):e0203625. doi: 10.1371/journal.pone.0203625. eCollection 2018.

12.

Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma.

Maemura K, Watanabe K, Ando T, Hiyama N, Sakatani T, Amano Y, Kage H, Nakajima J, Yatomi Y, Nagase T, Takai D.

Cancer Sci. 2018 Oct;109(10):3326-3335. doi: 10.1111/cas.13742. Epub 2018 Sep 6.

13.

Spontaneous Transformation from EGFR and ALK Wild-Type Lung Adenocarcinoma to Neuroendocrine Carcinoma.

Kage H, Kohsaka S, Shinozaki-Ushiku A, Ushiku T, Takai D, Nakajima J, Miyagawa K, Aburatani H, Mano H, Nagase T.

J Thorac Oncol. 2018 Jul;13(7):e126-e128. doi: 10.1016/j.jtho.2018.02.029. No abstract available.

14.

MicroRNA-21 in cancer-associated fibroblasts supportsĀ lung adenocarcinoma progression.

Kunita A, Morita S, Irisa TU, Goto A, Niki T, Takai D, Nakajima J, Fukayama M.

Sci Rep. 2018 Jun 11;8(1):8838. doi: 10.1038/s41598-018-27128-3.

15.

Cerebral Arterial Air Embolism after Diagnostic Flexible Fiberoptic Bronchoscopy: A Case Report and Review of the Literature.

Maemura K, Kage H, Isago H, Takeshima H, Makita K, Amano Y, Takai D, Ohishi N, Nagase T.

Case Rep Pulmonol. 2018 May 7;2018:7108215. doi: 10.1155/2018/7108215. eCollection 2018.

16.

Experimental studies on the biological effects of chronic low dose-rate radiation exposure in mice: overview of the studies at the Institute for Environmental Sciences.

Braga-Tanaka I 3rd, Tanaka S, Kohda A, Takai D, Nakamura S, Ono T, Tanaka K, Komura JI.

Int J Radiat Biol. 2018 May;94(5):423-433. doi: 10.1080/09553002.2018.1451048. Epub 2018 Apr 3. Review.

PMID:
29533133
17.

Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma.

Hiyama N, Ando T, Maemura K, Sakatani T, Amano Y, Watanabe K, Kage H, Yatomi Y, Nagase T, Nakajima J, Takai D.

Jpn J Clin Oncol. 2018 Apr 1;48(4):303-307. doi: 10.1093/jjco/hyy013.

18.

Acute Arterial Thrombosis during Postoperative Adjuvant Cisplatin-based Chemotherapy for Completely Resected Lung Adenocarcinoma.

Sato C, Okuda K, Tamiya H, Yamamoto K, Hoshina K, Narumoto O, Urushiyama H, Noguchi S, Amano Y, Watanabe K, Mitani A, Kage H, Tanaka G, Yamauchi Y, Takai D, Nagase T.

Intern Med. 2018 Feb 15;57(4):557-561. doi: 10.2169/internalmedicine.8996-17. Epub 2017 Dec 8.

19.

Utility of bronchoscopy in the definitive diagnosis of patients with haematological malignancies presenting with radiological abnormalities.

Makita K, Mikami Y, Matsuzaki H, Narumoto O, Takai D, Yatomi Y, Nagase T.

Clin Respir J. 2018 Apr;12(4):1381-1388. doi: 10.1111/crj.12666. Epub 2017 Jul 31.

PMID:
28752537
20.

Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.

Horie M, Kaczkowski B, Ohshima M, Matsuzaki H, Noguchi S, Mikami Y, Lizio M, Itoh M, Kawaji H, Lassmann T, Carninci P, Hayashizaki Y, Forrest ARR, Takai D, Yamaguchi Y, Micke P, Saito A, Nagase T.

Mol Cancer Res. 2017 Oct;15(10):1354-1365. doi: 10.1158/1541-7786.MCR-17-0191. Epub 2017 Jul 11.

21.

High expression of IRE1 in lung adenocarcinoma is associated with a lower rate of recurrence.

Sakatani T, Maemura K, Hiyama N, Amano Y, Watanabe K, Kage H, Fukayama M, Nakajima J, Yatomi Y, Nagase T, Takai D.

Jpn J Clin Oncol. 2017 Jun 1;47(6):543-550. doi: 10.1093/jjco/hyx031.

22.

Characterization of genome sequences and clinical features of coxsackievirus A6 strains collected in Hyogo, Japan in 1999-2013.

Ogi M, Yano Y, Chikahira M, Takai D, Oshibe T, Arashiro T, Hanaoka N, Fujimoto T, Hayashi Y.

J Med Virol. 2017 Aug;89(8):1395-1403. doi: 10.1002/jmv.24798. Epub 2017 Mar 14.

PMID:
28229467
23.

Successful treatment of pulmonary injury after nitrogen oxide exposure with corticosteroid therapy: A case report and review of the literature.

Kido Y, Mitani A, Isago H, Takeshima H, Narumoto O, Tanaka G, Yamauchi Y, Takai D, Ohishi N, Nagase T.

Respir Med Case Rep. 2017 Jan 17;20:107-110. doi: 10.1016/j.rmcr.2017.01.007. eCollection 2017.

24.

Cardiogenic syncope possibly related to bevacizumab-containing combination chemotherapy for advanced non-small cell lung cancer.

Chino H, Amano Y, Yamauchi Y, Matsuda J, Takeda N, Tanaka G, Takai D, Nagase T.

J Thorac Dis. 2016 Sep;8(9):2646-2650.

25.

Immunohistochemical pattern analysis of squamous cell carcinoma: Lung primary and metastatic tumors of head and neck.

Ichinose J, Shinozaki-Ushiku A, Nagayama K, Nitadori JI, Anraku M, Fukayama M, Nakajima J, Takai D.

Lung Cancer. 2016 Oct;100:96-101. doi: 10.1016/j.lungcan.2016.08.003. Epub 2016 Aug 10.

PMID:
27597287
26.

A case of Meigs' syndrome with preceding pericardial effusion in advance of pleural effusion.

Okuda K, Noguchi S, Narumoto O, Ikemura M, Yamauchi Y, Tanaka G, Takai D, Fukayama M, Nagase T.

BMC Pulm Med. 2016 May 10;16(1):71. doi: 10.1186/s12890-016-0241-1.

27.

Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma.

Ichinose J, Shinozaki-Ushiku A, Takai D, Fukayama M, Nakajima J.

Expert Rev Anticancer Ther. 2016;16(4):403-10. doi: 10.1586/14737140.2016.1147352. Epub 2016 Feb 16. Review.

PMID:
26813704
28.

The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.

Ishikawa R, Amano Y, Kawakami M, Sunohara M, Watanabe K, Kage H, Ohishi N, Yatomi Y, Nakajima J, Fukayama M, Nagase T, Takai D.

Jpn J Clin Oncol. 2016 Feb;46(2):185-9. doi: 10.1093/jjco/hyv187. Epub 2015 Dec 18.

29.

Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.

Watanabe K, Amano Y, Ishikawa R, Sunohara M, Kage H, Ichinose J, Sano A, Nakajima J, Fukayama M, Yatomi Y, Nagase T, Ohishi N, Takai D.

Cancer Med. 2015 Oct;4(10):1573-82. doi: 10.1002/cam4.505. Epub 2015 Aug 8.

30.
31.
32.

Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3.

Amano Y, Ishikawa R, Sakatani T, Ichinose J, Sunohara M, Watanabe K, Kage H, Nakajima J, Nagase T, Ohishi N, Takai D.

Biochem Biophys Res Commun. 2015 Feb 13;457(3):457-60. doi: 10.1016/j.bbrc.2015.01.014. Epub 2015 Jan 14.

33.

Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer.

Ichinose J, Watanabe K, Sano A, Nagase T, Nakajima J, Fukayama M, Yatomi Y, Ohishi N, Takai D.

Cancer Sci. 2014 Sep;105(9):1135-41. doi: 10.1111/cas.12472. Epub 2014 Sep 3.

34.

Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.

Ibrahim R, Matsubara D, Osman W, Morikawa T, Goto A, Morita S, Ishikawa S, Aburatani H, Takai D, Nakajima J, Fukayama M, Niki T, Murakami Y.

Hum Pathol. 2014 Jul;45(7):1397-405. doi: 10.1016/j.humpath.2014.02.013. Epub 2014 Feb 28.

PMID:
24775604
35.

[New era of laboratory testing. Topics: II. Particulars; 9. The recent advances of pulmonary function tests].

Takai D.

Nihon Naika Gakkai Zasshi. 2013 Dec 10;102(12):3167-73. Review. Japanese. No abstract available.

PMID:
24605566
36.

Disruption of the expression and function of microRNAs in lung cancer as a result of epigenetic changes.

Watanabe K, Takai D.

Front Genet. 2013 Dec 3;4:275. doi: 10.3389/fgene.2013.00275. Review.

37.

Successful Treatment of Mediastinal Unicentric Castleman's Disease Using Video-Assisted Thoracoscopic Surgery with Preoperative Embolization.

Amano Y, Takai D, Ohishi N, Shinozaki-Ushiku A, Fukayama M, Akahane M, Nakajima J, Nagase T.

Case Rep Med. 2013;2013:354507. doi: 10.1155/2013/354507. Epub 2013 Sep 30.

38.

Detection of novel paraja ring finger 2-fer tyrosine kinase mRNA chimeras is associated with poor postoperative prognosis in non-small cell lung cancer.

Kawakami M, Ishikawa R, Amano Y, Sunohara M, Watanabe K, Ohishi N, Yatomi Y, Nakajima J, Fukayama M, Nagase T, Takai D.

Cancer Sci. 2013 Nov;104(11):1447-54. doi: 10.1111/cas.12250. Epub 2013 Sep 5.

39.

A pilot study of salvage irinotecan monotherapy for advanced biliary tract cancer.

Sasaki T, Isayama H, Nakai Y, Takahara N, Satoh Y, Takai D, Kogure H, Yamamoto N, Hirano K, Tada M, Yatomi Y, Koike K.

Anticancer Res. 2013 Jun;33(6):2619-22.

PMID:
23749917
40.

High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases.

Morita S, Yoshida A, Goto A, Ota S, Tsuta K, Yokozawa K, Asamura H, Nakajima J, Takai D, Mori M, Oka T, Tamaru J, Itoyama S, Furuta K, Fukayama M, Tsuda H.

Am J Surg Pathol. 2013 Jun;37(6):924-32. doi: 10.1097/PAS.0b013e31827e1e83.

PMID:
23629442
41.

FER overexpression is associated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancer.

Kawakami M, Morita S, Sunohara M, Amano Y, Ishikawa R, Watanabe K, Hamano E, Ohishi N, Nakajima J, Yatomi Y, Nagase T, Fukayama M, Takai D.

Int J Clin Exp Pathol. 2013;6(4):598-612. Epub 2013 Mar 15.

42.

Combined large cell neuroendocrine carcinoma and adenocarcinoma with epidermal growth factor receptor mutation in a female patient who never smoked.

Yoshida Y, Ota S, Murakawa T, Takai D, Nakajima J.

Ann Thorac Cardiovasc Surg. 2014;20 Suppl:582-4. doi: 10.5761/atcs.cr.12.02217. Epub 2013 Mar 22.

43.

[Study on the analytical error factors and evaluation of an internal control gene for leukemia gene expression analysis].

Satoh Y, Yokota H, Takai D, Yatomi Y.

Rinsho Byori. 2012 Aug;60(8):740-7. Japanese.

PMID:
23198532
44.

Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer.

Takahara N, Nakai Y, Isayama H, Sasaki T, Satoh Y, Takai D, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Mohri D, Kawakubo K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tada M, Yatomi Y, Koike K.

Cancer Chemother Pharmacol. 2013 Jan;71(1):85-92. doi: 10.1007/s00280-012-1981-0. Epub 2012 Sep 29.

PMID:
23053265
45.

Isolation of an intertypic recombinant human adenovirus (candidate type 56) from the pharyngeal swab of a patient with pharyngoconjunctival fever.

Enomoto M, Okafuji T, Okafuji T, Chikahira M, Konagaya M, Hanaoka N, Adhikary AK, Takai D, Sugawara T, Hayashi Y, Oishi K, Fujimoto T.

Jpn J Infect Dis. 2012;65(5):457-9. No abstract available.

46.

Growth-associated hyperphosphatemia in young recipients accelerates aortic allograft calcification in a rat model.

Yamauchi H, Motomura N, Chung UI, Sata M, Takai D, Saito A, Ono M, Takamoto S.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):522-30. doi: 10.1016/j.jtcvs.2012.03.010. Epub 2012 Apr 17.

47.

Analysis for the combination expression of CK20, FABP1 and MUC2 is sensitive for the prediction of peritoneal recurrence in gastric cancer.

Satoh Y, Mori K, Kitano K, Kitayama J, Yokota H, Sasaki H, Uozaki H, Fukayama M, Seto Y, Nagawa H, Yatomi Y, Takai D.

Jpn J Clin Oncol. 2012 Feb;42(2):148-52. doi: 10.1093/jjco/hyr179. Epub 2011 Dec 15.

PMID:
22172348
48.

CpG island methylation of microRNAs is associated with tumor size and recurrence of non-small-cell lung cancer.

Kitano K, Watanabe K, Emoto N, Kage H, Hamano E, Nagase T, Sano A, Murakawa T, Nakajima J, Goto A, Fukayama M, Yatomi Y, Ohishi N, Takai D.

Cancer Sci. 2011 Dec;102(12):2126-31. doi: 10.1111/j.1349-7006.2011.02101.x. Epub 2011 Oct 12.

49.

Pulmonary venous invasion, determined by chest computed tomographic scan, as a potential early indicator of zygomycosis infection: a case series.

Kitagawa H, Watanabe K, Kage H, Inoh S, Goto A, Fukayama M, Nagase T, Ohishi N, Takai D.

J Thorac Imaging. 2012 Jul;27(4):W97-9. doi: 10.1097/RTI.0b013e3182282d17.

PMID:
21912300
50.

Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.

Watanabe K, Emoto N, Hamano E, Sunohara M, Kawakami M, Kage H, Kitano K, Nakajima J, Goto A, Fukayama M, Nagase T, Yatomi Y, Ohishi N, Takai D.

Int J Cancer. 2012 Jun 1;130(11):2580-90. doi: 10.1002/ijc.26254. Epub 2011 Sep 17.

Supplemental Content

Support Center